Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Sydney | OTHER |
Not provided
Not provided
Not provided
Not provided
This online, survey-based experiment will include 2,400 adults who are 65 years and older (n=1,200 each from the United States and Australia). Each participant will be asked to share their opinions on a hypothetical patient scenario developed by our multidisciplinary team. This work is expected to significantly contribute to the understanding of how older adults make decisions about deprescribing medications. The long-term goal is to enhance communication between older adults and clinicians so that medication regimens are optimized and align with care preferences. These results will directly inform future research on the impact of communication choices in clinical practice.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Source of recommendation - Physician | Experimental | Participants read a hypothetical scenario where a doctor recommends stopping aspirin. |
|
| Source of recommendation - Pharmacist | Experimental | Participants read a hypothetical scenario where a pharmacist recommends stopping aspirin. |
|
| Source of information - AI | Experimental | Participants read a hypothetical scenario where artificial intelligence is used to recommend stopping aspirin. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Additional harm information | Other | Participants received additional information about the harm of continuing aspirin. |
|
| Measure | Description | Time Frame |
|---|---|---|
| "How safe do you think it would be to continue taking aspirin?" measured on a 6-point Likert scale | Day 1 | |
| "How helpful do you think it would be to continue taking aspirin?" measured on a 6-point Likert scale | Day 1 |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sarah Vordenberg, PharmD, MPH | University of Michigan | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Michigan | Ann Arbor | Michigan | 48109 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000067490 | Prescription Drug Overuse |
| ID | Term |
|---|---|
| D063487 | Prescription Drug Misuse |
| D000076064 | Drug Misuse |
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Less information | Other | Participants will receive less information about the risk of harms of continuing aspirin. |
|
| D001523 | Mental Disorders |